(Q51362596)

English

Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis.

scientific article published in January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Pearl Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Annette Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Caroline Blaum

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Aleksandra Vlajnic

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Ling Gao

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Jeffrey Halter

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

language of work or name

0 references

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

60

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

51-59

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Standards of medical care in diabetes--2010.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Pharmacodynamic and Pharmacokinetic Features of Cabergoline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Parkinson's disease: clinical features, epidemiology and genetics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

The role of glucose, insulin and glucagon in the regulation of food intake and body weight

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Traditional reviews, meta-analyses and pooled analyses in epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Narrative review: a rational approach to starting insulin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

The growing burden of chronic disease in America

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Insulin glargine induced persistent intractable hypoglycemia, with variable presentations in older diabetic patients: an experience of 4 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2011.03773.X

21 January 2018

Identifiers

10.1111/J.1532-5415.2011.03773.X

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22239291

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51362596&oldid=2124459833"